The association between risk factors for tardive dyskinesia and phenylalanine-induced abnormal movements in schizophrenia

We examined whether an oral challenge dose of the amino acid phenylalanine (a dopamine precursor) exacerbates the abnormal movements of tardive dyskinesia (TD). We also examined age, gender, treatment duration, and baseline movement severity in relation to phenylalanine‐induced changes in movements....

Full description

Bibliographic Details

Published in:	Human psychopharmacology Vol. 16; no. 3; pp. 273 - 277
Main Authors:	Schultz, S. K., Ellingrod, V., Fleming, F. W., Andreasen, N. C.
Format:	Journal Article
Language:	English
Published:	Chichester, UK John Wiley & Sons, Ltd 01-04-2001
Subjects:	phenylalanine schizophrenia tardive dyskinesia
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!